Mario L. Suva

Mario L. Suva

Harvard University

H-index: 53

North America-United States

About Mario L. Suva

Mario L. Suva, With an exceptional h-index of 53 and a recent h-index of 49 (since 2020), a distinguished researcher at Harvard University, specializes in the field of adult and pediatric brain tumors, single-cell technologies.

His recent articles reflect a diverse array of research interests and contributions to the field:

Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma

The Virtual Child

Targeting of the CD161 inhibitory receptor enhances T-cell–mediated immunity against hematological malignancies

A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1

Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma

Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours

Glioma synapses recruit mechanisms of adaptive plasticity

Clinical trial links oncolytic immunoactivation to survival in glioblastoma

Mario L. Suva Information

University

Position

Associate Professor, Massachusetts General Hospital, Broad Institute, Harvard Medical School

Citations(all)

23885

Citations(since 2020)

17289

Cited By

12572

hIndex(all)

53

hIndex(since 2020)

49

i10Index(all)

81

i10Index(since 2020)

76

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Mario L. Suva Skills & Research Interests

adult and pediatric brain tumors

single-cell technologies

Top articles of Mario L. Suva

Title

Journal

Author(s)

Publication Date

Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma

medRxiv

Avishay Spitzer

Simon Gritsch

Hannah R Weisman

L Nicolas Gonzalez Castro

Masashi Nomura

...

2021/11/20

The Virtual Child

Cancer Discovery

Richard J Gilbertson

Sam Behjati

Anna-Lisa Böttcher

Marianne E Bronner

Matthew Burridge

...

2024/4/4

Targeting of the CD161 inhibitory receptor enhances T-cell–mediated immunity against hematological malignancies

Blood

Francesca Alvarez Calderon

Byong H Kang

Oleksandr Kyrysyuk

Shiwei Zheng

Hao Wang

...

2024/3/21

A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1

Nature Communications

Ling Hai

Dirk C Hoffmann

Robin J Wagener

Daniel D Azorin

David Hausmann

...

2024/2/6

Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma

Acta Neuropathologica

Richard Drexler

Robin Khatri

Ulrich Schüller

Alicia Eckhardt

Alice Ryba

...

2024/6

Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours

Nature

Avishai Gavish

Michael Tyler

Alissa C Greenwald

Rouven Hoefflin

Dor Simkin

...

2023/6/15

Glioma synapses recruit mechanisms of adaptive plasticity

bioRxiv

Kathryn R Taylor

Tara Barron

Helena Zhang

Alexa Hui

Griffin Hartmann

...

2021/1/1

Clinical trial links oncolytic immunoactivation to survival in glioblastoma

Nature

Alexander L Ling

Isaac H Solomon

Ana Montalvo Landivar

Hiroshi Nakashima

Jared K Woods

...

2023/11/2

Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models

Proceedings of the National Academy of Sciences

Meenal Datta

Sampurna Chatterjee

Elizabeth M Perez

Simon Gritsch

Sylvie Roberge

...

2023/2/7

Programs, origins, and niches of immunomodulatory myeloid cells in gliomas

bioRxiv

2023/10/27

DrugMap: A quantitative pan-cancer analysis of cysteine ligandability

Cell

Mariko Takahashi

Harrison B Chong

Siwen Zhang

Tzu-Yi Yang

Matthew J Lazarov

...

2023/10/23

Integrative spatial analysis reveals a multi-layered organization of glioblastoma

Cell

Alissa C Greenwald

Noam Galili Darnell

Rouven Hoefflin

Dor Simkin

Christopher W Mount

...

2023/7/8

Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model

Frontiers in immunology

J Bryan Iorgulescu

Neil Ruthen

Ryuhjin Ahn

Eleni Panagioti

Prafulla C Gokhale

...

2023/12/28

Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy

Science Advances

Lai Man Natalie Wu

Feng Zhang

Rohit Rao

Mike Adam

Kai Pollard

...

2022/11/2

Oncometabolite d-2HG alters T cell metabolism to impair CD8+ T cell function

Science

Giulia Notarangelo

Jessica B Spinelli

Elizabeth M Perez

Gregory J Baker

Kiran Kurmi

...

2022/9/30

Elucidating the diversity of malignant mesenchymal states in glioblastoma by integrative analysis

Genome medicine

Rony Chanoch-Myers

Adi Wider

Mario L Suva

Itay Tirosh

2022/9/19

Defining ancestry, heritability and plasticity of cellular phenotypes in somatic evolution

bioRxiv

Joshua S Schiffman

Andrew R D’Avino

Tamara Prieto

Yakun Pang

Yilin Fan

...

2022/12/30

Microenvironmental landscape of human melanoma brain metastases in response to immune checkpoint inhibition

Cancer immunology research

Christopher Alvarez-Breckenridge

Samuel C Markson

Jackson H Stocking

Naema Nayyar

Matt Lastrapes

...

2022/8/3

BAF complex maintains glioma stem cells in pediatric H3K27M glioma

Cancer discovery

Eshini Panditharatna

Joana G Marques

Tingjian Wang

Maria C Trissal

Ilon Liu

...

2022/12/2

Single-cell analysis and functional characterization uncover the stem cell hierarchies and developmental origins of rhabdomyosarcoma

Nature cancer

Yun Wei

Qian Qin

Chuan Yan

Madeline N Hayes

Sara P Garcia

...

2022/8

See List of Professors in Mario L. Suva University(Harvard University)

Co-Authors

H-index: 116
Bradley Bernstein

Bradley Bernstein

Harvard University

H-index: 64
Michelle Monje-Deisseroth

Michelle Monje-Deisseroth

Stanford University

H-index: 51
Itay Tirosh

Itay Tirosh

Weizmann Institute of Science

academic-engine